XENE
Xenon Pharmaceuticals Inc Earnings
$39.13
Earnings Summary
Net Profits | $-90.9Mn |
Highlights
Net Profits:
Xenon Pharmaceuticals Inc’s net profit fell -44.76% since last year same period to $-90.9Mn in the Q3 2025. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated -7.31% fall in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Xenon Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | -1.15 |
EPS Estimate Current Year | -1.15 |
Highlights
EPS Estimate Current Quarter:
Xenon Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -1.15 - a -16.16% fall from last quarter’s estimates.
EPS Estimate Current Year:
Xenon Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -1.15.
Key Ratios
Key ratios of the Xenon Pharmaceuticals Inc post its Q3 2025 earnings
Earning Per Share (EPS) | 0 |
Highlights
Earning Per Share (EPS):
Xenon Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Xenon Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-12 | -0.9 | -0.83 | 7.49% |
2025-11-03 | -1.15 | 0 | 100% |
2025-08-11 | -0.99 | 1.07 | 208.08% |
